ArticleAntimicrobial agents and chemotherapy2018

Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169).

Andréanne Lupien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.